B

Bio-Gene Technology Ltd
ASX:BGT

Watchlist Manager
Bio-Gene Technology Ltd
ASX:BGT
Watchlist
Price: 0.031 AUD Market Closed
Market Cap: AU$9.5m

Net Margin

-608%
Current
Declining
by 181.5%
vs 3-y average of -426.5%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-608%
=
Net Income
AU$-2.6m
/
Revenue
AU$425.1k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-608%
=
Net Income
AU$-2.6m
/
Revenue
AU$425.1k

Peer Comparison

Country Company Market Cap Net
Margin
AU
Bio-Gene Technology Ltd
ASX:BGT
9.5m AUD
Loading...
US
Corteva Inc
NYSE:CTVA
50.7B USD
Loading...
CA
Nutrien Ltd
TSX:NTR
47B CAD
Loading...
CN
Qinghai Salt Lake Industry Co Ltd
SZSE:000792
175.5B CNY
Loading...
CL
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
20.9B USD
Loading...
CN
Zangge Mining Co Ltd
SZSE:000408
136.2B CNY
Loading...
US
CF Industries Holdings Inc
NYSE:CF
14.9B USD
Loading...
SA
SABIC Agri-Nutrients Company SJSC
SAU:2020
53.8B SAR
Loading...
NO
Yara International ASA
OSE:YAR
114.5B NOK
Loading...
CN
Shandong Hualu-Hengsheng Chemical Co Ltd
SSE:600426
77.5B CNY
Loading...
RU
PhosAgro PAO
MOEX:PHOR
830.7B RUB
Loading...

Market Distribution

Lower than 71% of companies in Australia
Percentile
29th
Based on 4 004 companies
29th percentile
-608%
Low
-16 177 900% — -544.7%
Typical Range
-544.7% — 3.1%
High
3.1% — 3 174 540%
Distribution Statistics
Australia
Min -16 177 900%
30th Percentile -544.7%
Median -27.7%
70th Percentile 3.1%
Max 3 174 540%

Bio-Gene Technology Ltd
Glance View

Market Cap
9.5m AUD
Industry
Chemicals

Bio-Gene Technology Ltd. is a development company enabling the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-29. The Company’s principal activity is to develop and commercialize insecticide products. The company is focused on enabling novel insecticides to address the global problem of insecticide resistance and toxicity. Its novel platform technology is based on naturally occurring beta-triketones. The Company’s lead beta-triketone insecticide products include Flavocide and Qcide. Flavocide is a synthetically produced nature-identical compound. Testing of Flavocide has been undertaken and continues to be performed by both government research laboratories as well as by commercial collaborators. Qcide natural oil with high levels of tasmanone. The oil is extracted from the leaves of the Gympie Messmate, by utilizing a steam distillation process.

BGT Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-608%
=
Net Income
AU$-2.6m
/
Revenue
AU$425.1k
What is Bio-Gene Technology Ltd's current Net Margin?

The current Net Margin for Bio-Gene Technology Ltd is -608%, which is below its 3-year median of -426.5%.

How has Net Margin changed over time?

Over the last 3 years, Bio-Gene Technology Ltd’s Net Margin has decreased from -312.5% to -608%. During this period, it reached a low of -608% on Jul 30, 2025 and a high of -312.5% on May 30, 2022.

Back to Top